The US tariff reset is increasingly reshaping the ex-China battery market as a supply-chain design issue, not just a cost issue. With EV growth slowing and volatility rising, ESS—driven by ...
Closed a $35.7 million investment in September from aPremium, Sangatang Group, and CDH Investments, resulting in 10.3 million shares issued at $1.04 per share. Net sales -- Fourth quarter net sales ...
Natural gas prices have soared again this week as the Middle East conflict disrupts supplies - and British households are set ...
Share repurchase -- $30 million repurchased since July 2025 under a $50 million program; $9 million repurchased since the ...
Surgeon adoption -- Surgeon user base grew 23% in fiscal Q4 2025 and 20% for the year; incremental adoption and increased ...
Q4 2025 Earnings Call February 27, 2026 9:00 AM ESTCompany ParticipantsJohn Kompa - Director of Investor RelationsLouis Borgmann ...
Cash and cash equivalents -- $1,017 million at year-end, including treasury securities; management described this as ...
AbbVie, RTX and IBM headline Zacks??? top analyst picks after strong earnings beats and solid backlog, cloud and AI-driven momentum.
Net sales of $233.7 million, down 2.6% year-over-yearNet loss of $15.9 million or 6.8% of net sales; adjusted EBITDA margin of 3.1%Narrowed FY26 ...
Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsPatrick Miles - Executive Chairman, CEO ...
Fiscal Fourth Quarter 2025 Fourth quarter net sales of $14.9 billion – above high end of guidance range – up 11.5% from the prior-year period in U.S. dollars, and up 9.1% from the prior-year period on ...
Press releaseCommuniqué de pressePersbericht Syensqo fourth quarter and full year 2025 results Full year free cash flow of €356 million, above prior outlook; Pro forma full year underlying EBITDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results